[EN] 1, 2 DISUBSTITUTED HETEROCYCLIC COMPOUNDS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES À SUBSTITUTION EN 1,2
申请人:ENVIVO PHARMACEUTICALS INC
公开号:WO2009158393A1
公开(公告)日:2009-12-30
1,2-disubstituted heterocyclic compounds which are inhibitors of phosphodiesterase 10 are described. Also described are processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of mammals, including human(s) for central nervous system (CNS) disorders and other disorders which may affect CNS function. Among the disorders which may be treated are neurological, neurodegenerative and psychiatric disorders including, but not limited to, those associated with cognitive deficits or schizophrenic symptoms.
描述了一种抑制磷酸二酯酶10的1,2-二取代杂环化合物。还描述了这些化合物在治疗哺乳动物,包括人类的中枢神经系统(CNS)疾病和可能影响CNS功能的其他疾病中的过程、药物组成、药物制剂和药物用途。可以治疗的疾病包括神经病、神经退行性疾病和精神疾病,包括但不限于与认知缺陷或精神分裂症症状相关的疾病。